Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

TRACERx NSCLC - whole genome sequencing for ctDNA study

ABSTRACT: TRACERx NSCLC - whole genome sequencing for ctDNA study

PROVIDER: PRJEB72492 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Whole genome shallow sequencing of ctDNA from leiomyosarcoma patients

Project description:Whole genome shallow sequencing of ctDNA from leiomyosarcoma patients

| PRJEB22076 | ENA

whole genome shallow sequencing of ctDNA from pediatric solid tumors

Project description:whole genome shallow sequencing of ctDNA from pediatric solid tumors

| PRJEB32931 | ENA

Analysis of ctDNA methylation induced by ionizing to different ograns

Project description:This study aims to compared ctDNA methylation status induced by ionizing to different ograns. SD rats were irradiated with local radaition to brain, lung or skin. Serum was collected and subjiected to ctDNA extraction. ctDNA were then treated by methylation-sensive bisulfite and sequencing.

2021-12-23 | GSE163763 | GEO

Karonga Prevention Study (KPS) : whole genome sequencing in a whole population

Project description:Karonga Prevention Study (KPS) : whole genome sequencing in a whole population

| PRJEB2794 | ENA

Genomic Psychiatry Cohort (GPC) Whole Genome Sequencing Pilot Study

Project description:Genomic Psychiatry Cohort (GPC) Whole Genome Sequencing Pilot Study

| PRJNA300594 | ENA

Whole genome sequencing to study of pathogenic Candida strains

Project description:Whole genome sequencing to study of pathogenic Candida strains

| PRJEB1831 | ENA

Whole Genome Association Study of Mammographic Density

Project description:Whole Genome Association Study of Mammographic Density

| PRJNA292935 | ENA

ctDNA methylation markers in diagnosis and prognosis of hepatocellular carcinoma

Project description:To develop diagnostic and prognostic biomarkers, we compared methylation profiles of HCC tissues and normal blood by analyzing 485,000 CpG markers and identified a HCC enriched methylation marker panel compared to that of normal blood. We found there was a highly correlation of methylation profiles between DNA from HCC cancer tissue and matched plasma ctDNA within the same patient. We then selected 10 markers from this panel and created a combined diagnosis score (cd-score) which showed high diagnostic specificity and sensitivity in both a training cohort and an independent validation cohort. We also showed the cd-score correlate highly with tumor load, treatment response and stage and is superior to that by AFP. We also showed the cd-score correlate highly with tumor load, treatment response and stage and is superior to that by AFP. Additional, we generated 8 markers from unicox and LASSO-cox analysis and created a combined prognosis score (cp-score) which could predict prognosis and survival. Together, these findings demonstrated the utility of ctDNA methylation markers in the diagnosis, treatment evaluation and prognosis of HCC.

2019-01-01 | GSE93203 | GEO

Whole-exome Sequencing Study of Diabetic Nephropathy

Project description:Whole-exome Sequencing Study of Diabetic Nephropathy

| PRJNA1021759 | ENA

Whole-exome Sequencing Study of Diabetic Nephropathy

Project description:Whole-exome Sequencing Study of Diabetic Nephropathy

| PRJNA1021758 | ENA